Ensayo clínico en reclutamiento = ; Ensayos clínico en curso = ; Financiado por un miembro del IRDiRC = ; Miembro de una ERN =

Ensayo(s) clínico(s) nacional(es)

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

Sequoia Study: A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure - AT

Institution: Information not provided - AT

Para más detalles

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

Redwood Study: A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure - AT

Institution: Information not provided - AT

Para más detalles

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

OAK: A Phase 3, 182-week, Open-Label, Extension Study to Investigate the Safety and Tolerability of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension (Symptomatic nOH) in Subjects With Primary Autonomic Failure - AT

Institution: Information not provided - AT

Para más detalles